Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Complement-mediated enhancement of HIV-1 infection in peripheral blood mononuclear cells.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  1. Molecular imaging in Libman-Sacks endocarditis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Mycobacterium bovis meningitis in young Nigerian-born male

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Undetectable hepatitis C virus RNA during syphilis infection in two HIV/HCV-co-infected patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: a comparison with the general population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Antibacterial use in the Faroe Islands, Iceland, and Denmark 1999-2011

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
We investigated if complement-mediated enhancement of HIV infection occurs in peripheral blood mononuclear cells (PBMC). In 7 experiments, we evaluated the effect of human complement on HIVIIIB infection in vitro. We measured HIV antigen production on day 4 and found that pre-incubation of HIV with complement led to enhanced production of antigen with a median enhancement of 2.5-fold (range 1.1-6.8). This complement-mediated increase in antigen production was statistically significant (p < 0.02). Complement-mediated enhancement of HIV infection was also tested in CD4 cells enriched from PBMC, and CD4 cells persistently gave higher levels of infection enhancement than PBMC. Thus, CD4 cells appear to be sufficient for complement-mediated enhancement of HIV infection to occur. In addition, we tested if it was possible to detect complement-mediated enhancement of primary HIV isolates in PBMC. We tested 3 isolates and found only a minor effect on antigen production (median enhancement 1.2-fold, range 0.6-1.5). Furthermore, addition of HIV-specific antibodies in combination with complement resulted in enhanced antigen production in 2/3 sera tested. However, the combination of complement and antibodies resulted in only a minor increase in enhancement of HIV infection compared to that obtained with complement alone. Finally, we found evidence of complement-mediated enhancement of HIV infection in resting PBMC. In conclusion, we demonstrated that complement-mediated enhancement of HIV infection does occur in vitro in PBMC.
Bidragets oversatte titelComplement-mediated enhancement of HIV-1 infection in peripheral blood mononuclear cells.
OriginalsprogEngelsk
TidsskriftScandinavian Journal of Infectious Diseases
Vol/bind29
Udgave nummer5
Sider (fra-til)447-452
Antal sider6
ISSN0036-5548
StatusUdgivet - 1997

ID: 32536535